Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
April 25 2024
The effect of a Mediterranean diet on both gastrointestinal (GI) and psychological symptoms among people with irritable bowel syndrome (IBS) was recen...
The Lancet has just published the results of the first randomized and controlled trial evaluating the effect of hearing aids on cognitive decline and dementia when given to older adults with hearing loss. A substantial body of evidence suggests that hearing loss, which is quite common among older adults, is associated with a greater risk for both cognitive decline and dementia. Additionally, a systematic review of observational studies published in JAMA Neurology earlier this year indicates that the use of hearing restoration devices mitigates some of this risk. However, until now no interventional trials have yet been conducted.
Titled the ACHIEVE (Aging and Cognitive Health Evaluation in Elders) study, 2 separate cohorts of adults aged 70-84 were randomized (but unblinded) to receive either audiologist-supplied hearing aids or an evidence-based program taught by a certified health educator. They were evaluated with a variety of cognition-based exams annually over a 3-year period.
Although overall no effect of hearing aids was observed, the results were quite encouraging. When analysis was restricted to one of the cohorts, participants in ARIC (Atherosclerosis Risk in Communities), had a 48% reduction in cognitive decline over the 3-year period when given hearing aids. This cohort was considered to be at higher risk for decline compared to the second cohort (which was younger, had higher education levels, fewer cardiovascular risk factors, etc.). The rate of decline in ARIC was greater, perhaps allowing for an effect to be observed within only a 3-year period. This study clearly shows benefits for those at high risk of decline, and it remains possible that a benefit exists even for those not considered high-risk, but 3 years may not be enough time to detect it.
Submit this form and you'll receive our latest news and updates.
Results of a randomized controlled trial performed to evaluate the effectiveness of a prebiotic supplement on both muscl...
Learn moreResults of a cross-sectional study were recently published in the Journal of Translational Medicine, detailing the assoc...
Learn moreThe results of a 10-year longitudinal study were recently published in The Lancet Healthy Longevity, detailing the assoc...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment